JP2009538823A5 - - Google Patents

Info

Publication number
JP2009538823A5
JP2009538823A5 JP2008556382A JP2008556382A JP2009538823A5 JP 2009538823 A5 JP2009538823 A5 JP 2009538823A5 JP 2008556382 A JP2008556382 A JP 2008556382A JP 2008556382 A JP2008556382 A JP 2008556382A JP 2009538823 A5 JP2009538823 A5 JP 2009538823A5
Authority
JP
Japan
Prior art keywords
chroman
tetramethyl
succinate
hydroxy
methylpentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008556382A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538823A (ja
JP5256049B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/004337 external-priority patent/WO2007098139A2/en
Publication of JP2009538823A publication Critical patent/JP2009538823A/ja
Publication of JP2009538823A5 publication Critical patent/JP2009538823A5/ja
Application granted granted Critical
Publication of JP5256049B2 publication Critical patent/JP5256049B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008556382A 2006-02-21 2007-02-21 抗癌剤 Expired - Fee Related JP5256049B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77510706P 2006-02-21 2006-02-21
US60/775,107 2006-02-21
PCT/US2007/004337 WO2007098139A2 (en) 2006-02-21 2007-02-21 Anticancer agents

Publications (3)

Publication Number Publication Date
JP2009538823A JP2009538823A (ja) 2009-11-12
JP2009538823A5 true JP2009538823A5 (https=) 2011-03-03
JP5256049B2 JP5256049B2 (ja) 2013-08-07

Family

ID=38437941

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008556382A Expired - Fee Related JP5256049B2 (ja) 2006-02-21 2007-02-21 抗癌剤

Country Status (6)

Country Link
US (2) US20080009545A1 (https=)
EP (1) EP1986635A4 (https=)
JP (1) JP5256049B2 (https=)
AU (1) AU2007217810B2 (https=)
CA (1) CA2643546A1 (https=)
WO (1) WO2007098139A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2414205T3 (es) 2006-06-02 2013-07-18 The Ohio State University Research Foundation Agentes terapéuticos para el tratamiento de linfoma de células del manto
CA2726175A1 (en) * 2008-05-27 2009-12-23 Memorial Sloan-Kettering Cancer Center Models for combinatorial perturbations of living biological systems
JP2012523458A (ja) * 2009-04-13 2012-10-04 ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション タンパク質ホスファターゼ2a活性化剤
CA2759011A1 (en) * 2009-04-17 2010-10-21 The Ohio State University Research Foundation Antiadhesion agents
US8309768B2 (en) 2010-11-29 2012-11-13 The Ohio State University Research Foundation FTY720-derived anticancer agents
US20140197449A1 (en) * 2013-01-14 2014-07-17 Electronics And Telecommunications Research Institute Semiconductor rectifier device

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680749A (en) * 1951-12-01 1954-06-08 Eastman Kodak Co Water-soluble tocopherol derivatives
US3459774A (en) * 1967-02-06 1969-08-05 Eisai Co Ltd Method of producing alpha-tocopheryl acid succinate
DE2822324C3 (de) * 1978-05-22 1981-02-26 Basf Ag, 6700 Ludwigshafen Herstellung von Vitamin-E-Trockenpulver
JPS59222415A (ja) * 1983-05-31 1984-12-14 Kuraray Co Ltd 免疫調節剤
US4751224A (en) * 1983-07-21 1988-06-14 Brown University Research Foundation Treatment of metastasis
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US6335358B1 (en) * 1995-04-12 2002-01-01 President And Fellows Of Harvard College Lactacystin analogs
ES2230571T3 (es) * 1995-12-28 2005-05-01 Mitsubishi Pharma Corporation `composicion farmaceutica destinada para la administracion topica que comprende el 2-amino-2-(2-(4-octilfenil)etil) propan-1,3-diol para el tratamiento de las enfermedades causadas por una alteracion inmunitaria.
US6476004B1 (en) * 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
US6004656A (en) * 1997-11-14 1999-12-21 3M Innovative Properties Company Color changeable device
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
JP2002526446A (ja) * 1998-09-23 2002-08-20 リサーチ ディベロップメント ファンデーション トロフェロール、トコトリエノール、その他のクロマン及び側鎖誘導体、並びにそれらの利用
US6770672B1 (en) * 1998-09-23 2004-08-03 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
KR100847678B1 (ko) * 2000-02-11 2008-07-23 리서치 디벨럽먼트 파운데이션 토코페롤, 토코트리에놀, 다른 크로만 및 측쇄 유도체, 및이들의 용도
US20040248971A1 (en) * 2001-07-27 2004-12-09 Shuyuan Yeh Use of vitamin e succinate and antiandrogen combination
US6858227B1 (en) * 2001-11-21 2005-02-22 Sonus Pharmaceuticals, Inc. Vitamin E conjugates
US20050215531A1 (en) * 2002-05-16 2005-09-29 Thomas Baumruker Use of edg receptor binding agents in cancer
WO2005025553A2 (en) * 2003-09-12 2005-03-24 Neuronova Ab Treatment of disorders of nervous systemsystem with fty720
WO2005033092A1 (en) * 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. Chroman derivatives
KR101346527B1 (ko) * 2005-12-15 2013-12-31 미쓰비시 타나베 파마 코퍼레이션 아민 화합물 및 그 의약 용도
TWI439263B (zh) * 2007-06-14 2014-06-01 Mitsubishi Tanabe Pharma Corp 胺化合物及其醫藥用途

Similar Documents

Publication Publication Date Title
JP2009538823A5 (https=)
EP2682387A3 (en) C7-fluoro substituted tetracycline compounds
EA200701745A1 (ru) Циклопропанкарбоксамидные производные
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
EA201200763A1 (ru) Замещенные производные карбамоилметиламиноуксусной кислоты в качестве новых ингибиторов nep
EP1797878A3 (en) Benzothiazole derivatives
EP2592070A3 (en) Tetrazole-substituted arylamides
RU2006113638A (ru) Антагонисты рецептора тромбина
ATE288887T1 (de) Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
JP2003528852A5 (https=)
JP2006526031A5 (https=)
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
EP1988898A2 (en) Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
EA200971086A1 (ru) Фармацевтические композиции и способ лечения шизофрении
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
JP7036871B2 (ja) 光学活性ピラノクロメニルフェノール誘導体およびそれを含む薬学的組成物
JP2003306481A5 (https=)
EA200801529A1 (ru) Кристаллические формы 1-бензоил-4-[2-[4-метокси-7-(3-метил-1h-1,2,4-1-ил)-1-[(фосфонокси)метил]-1h-пирроло[2,3-c]пиридин-3-ил]-1,2-диоксоэтил]пиперазина
KR20130121902A (ko) 신규 화합물 및 그 의약 용도
RU2009128970A (ru) Производные изосорбидмононитрата для лечения кишечных заболеваний
JP2011529942A5 (https=)
JP2018530617A5 (https=)
ES2435643T3 (es) Derivados de rosuvastatina y de atorvastatina
RU2011101661A (ru) Пиримидилсульфонамидное производное и его применение для лечения хемокин-опосредованных заболеваний
JP2009536665A5 (https=)